[{"address1": "21925 W. Field Parkway", "address2": "Suite 235", "city": "Deer Park", "state": "IL", "zip": "60010-7278", "country": "United States", "phone": "847 787 7361", "website": "https://www.etonpharma.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of tyrosinemia type 1. It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.", "fullTimeEmployees": 30, "maxAge": 86400, "priceHint": 4, "previousClose": 3.3, "open": 3.26, "dayLow": 3.24, "dayHigh": 3.4051, "regularMarketPreviousClose": 3.3, "regularMarketOpen": 3.26, "regularMarketDayLow": 3.24, "regularMarketDayHigh": 3.4051, "beta": 1.271, "trailingPE": 111.333336, "forwardPE": 12.37037, "volume": 50485, "regularMarketVolume": 50485, "averageVolume": 52496, "averageVolume10days": 41050, "averageDailyVolume10Day": 41050, "bid": 2.39, "ask": 4.17, "bidSize": 200, "askSize": 200, "marketCap": 85806600, "fiftyTwoWeekLow": 2.42, "fiftyTwoWeekHigh": 5.81, "priceToSalesTrailing12Months": 2.5013585, "fiftyDayAverage": 3.5048, "twoHundredDayAverage": 4.04055, "currency": "USD", "enterpriseValue": 74258480, "profitMargins": 0.02661, "floatShares": 21941024, "sharesOutstanding": 25690600, "sharesShort": 85174, "sharesShortPriorMonth": 148056, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.0033000002, "heldPercentInsiders": 0.054169998, "heldPercentInstitutions": 0.28494, "shortRatio": 1.48, "shortPercentOfFloat": 0.0034999999, "impliedSharesOutstanding": 25690600, "bookValue": 0.603, "priceToBook": 5.538972, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": 913000, "trailingEps": 0.03, "forwardEps": 0.27, "enterpriseToRevenue": 2.165, "enterpriseToEbitda": 52.442, "52WeekChange": -0.17121589, "SandP52WeekChange": 0.26238096, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "ETON", "underlyingSymbol": "ETON", "shortName": "Eton Pharmaceuticals, Inc.", "longName": "Eton Pharmaceuticals, Inc.", "firstTradeDateEpochUtc": 1542119400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "fbcd977f-686a-3d1e-ae47-b3ae800e35f4", "messageBoardId": "finmb_435353222", "gmtOffSetMilliseconds": -14400000, "currentPrice": 3.34, "targetHighPrice": 8.0, "targetLowPrice": 8.0, "targetMeanPrice": 8.0, "targetMedianPrice": 8.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 16655000, "totalCashPerShare": 0.648, "ebitda": 1416000, "totalDebt": 5107000, "quickRatio": 1.366, "currentRatio": 1.586, "totalRevenue": 34304000, "debtToEquity": 32.961, "revenuePerShare": 1.335, "returnOnAssets": 0.01238, "returnOnEquity": 0.0683, "freeCashflow": 2093125, "operatingCashflow": 5890000, "revenueGrowth": 0.502, "grossMargins": 0.66236997, "ebitdaMargins": 0.041279998, "operatingMargins": -0.100430004, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-24"}]